基于CT影像组学预测肺腺癌ALK与EGFR突变
回顾性纳入503例病理证实的肺腺癌患者,从CT提取瘤内及瘤周影像组学特征,构建两步法模型分别预测ALK重排和EGFR突变。瘤内模型预测ALK的AUC在开发集和验证集分别为0.77和0.68,预测EGFR的AUC分别为0.64和0.62。影像组学加入临床特征模型可提升预测价值,但瘤周特征未带来额外改善。
要点
- CT影像组学可同时预测肺腺癌ALK重排和EGFR突变状态。
- 瘤内影像组学模型对ALK的预测效能优于对EGFR的预测。
- 瘤周影像组学特征未提升模型预测性能。
诊断标准与关键数值
- 预测ALK重排的瘤内影像组学模型AUC在开发集为0.77,验证集为0.68。
- 预测EGFR突变的瘤内影像组学模型AUC在开发集为0.64,验证集为0.62。
- 影像组学联合临床特征模型与临床模型比较,Obuchowski指数在开发集为0.76 vs. 0.66(p < 0.001),验证集为0.69 vs. 0.61(p = 0.075)。
局限性
- 回顾性研究设计。
- 验证集样本量及中心数未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop and validate a CT-based radiomic model to simultaneously diagnose anaplastic lymphoma kinase (ALK) rearrangements and epidermal growth factor receptor (EGFR) mutation status of lung adenocarcinoma and to assess whether peritumoural radiomic features add value in the prediction of mutation status.
METHODS: 503 patients with pathologically proven lung adenocarcinoma containing information on the mutation status were retrospectively included. Intratumoural and peritumoural radiomic features of the primary lesion were extracted from CT. We proposed two-level stepwise binary radiomics-based classification models to diagnose ALK (step1) and EGFR mutation status (step2). The performance of proposed models and added value of peritumoural radiomic features were evaluated by using the areas under receiver operating characteristic curves (AUC) and Obuchowski index in the development and validation sets.
RESULTS: Regarding the prediction of ALK rearrangement, the diagnostic performance of the intratumoural radiomic model showed the AUC of 0.77 and 0.68 for the development and validation sets, respectively. As for EGFR mutation, the diagnostic performance of the intratumoural radiomic model showed the AUCs of 0.64 and 0.62 for the development and validation sets, respectively. The radiomics added value to the model based on clinical features (development set [radiomics + clinical model vs. clinical model]: Obuchowski index, 0.76 vs. 0.66, p < 0.001; validation set: 0.69 vs. 0.61, p = 0.075). Adding peritumoural features resulted in no improvement in terms of model performance.
CONCLUSION: The CT radiomics-based model allowed the simultaneous prediction of the presence of ALK and EGFR mutations while adding value to the clinical features.
引用
- Choe J, Lee SM, Kim W, et al. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma. Eur J Radiol. 2021. PMID: 33862316. doi:10.1016/j.ejrad.2021.109710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。